Capecitabine in combination with leucovorin and oxaliplatin as adjuvant chemotherapy in the treatment of advanced colorectal cancer
卡培他濱聯(lián)合甲酰四氫葉酸鈣和奧沙利鉑治療晚期結直腸癌的臨床觀(guān)察
Objective To evaluate the efficacy and safety of oxaliplat in combined with fluorouracil(5-FU) and leucovorin (LV) in the treatment of patie nts with advanced gastric cancer.
治療組應用奧沙利鉑 80mg/m2 靜脈滴注第 1、8、15天 ,5 氟脲嘧啶 5 0 0mg/m2 靜脈滴注第 1、8、15天 ,甲酰四氫葉酸鈣 10 0mg/d靜脈滴注第 1、8、15天。
Oxaliplatin combining fluorouracil and folinic acid in treatment of locally advanced and metastatic gastric cancer;
奧沙利鉑聯(lián)合5-氟尿嘧啶和甲酰四氫葉酸治療晚期和復發(fā)性胃癌的臨床分析
BACKGROUND & AIM: To study the DNA damage of BALE/ c mice caused by multiple treatment with low-dose methotrexate (MTX)and the protective effect of folinic acid (FA).
背景與目的:研究多次低劑量應用甲氨蝶呤所致BALB/c小鼠淋巴細胞及骨髓細胞:DNA的損傷,并探討甲酰四氫葉酸對其損傷的保護作用。
Methods A total of 48 advanced colctal cancer patients were enrolled into test,who were treated with oxaliplatin and LV/5FU for three cycles,which combine oxaliplatin 130 mg/m~2(d1) and LV/5FU [leucovorin(LV) 400mg/m~2 as a 2-hour infusion(d2),5-fluorouracil(5-FU) 3.
目的觀(guān)察應用草酸鉑聯(lián)合氟尿嘧啶、甲酰四氫葉酸治療晚期大腸癌的客觀(guān)療效及不良反應。
Objective To observe the efficacy and safety of combination chemotherapy of Epidoxorubicin(EPI),Leucovorin(CF),5-Fluorouracil(5-Fu) and Cisplation(DDP) for gastric cancer.
目的觀(guān)察表阿霉素(EPI)、甲酰四氫葉酸(CF)、5氟-尿嘧啶(5-Fu)和順鉑(DDP)聯(lián)合化療治療晚期胃癌的療效和不良反應。
The adjuvant chemotherapy (AC) with leucovorin/5- fluorouracil (LV/5-FU) was carried out within two weeks after radical operation.
在手術(shù)后2周內開(kāi)始予以L(fǎng)V／5-FU(甲酰四氫葉酸／5-氟尿嘧啶)輔助化療。
Evaluation of 5-Fluorouracil(5-Fu) Combined with Calcium Formyltetrahydrofolate (CF) for the Treatment of Liver Metastatic Tumor;
5-氟脲嘧啶和甲酰四氫葉酸鈣聯(lián)合治療肝轉移瘤的療效評價(jià)
[Objective] To observe the efficacy and toxicity of combination chemotherapy with HCPT/CF/5Fu in advanced colorectal cancer.
d1～5,甲酰四氫葉酸鈣200mgivd1～5,5-氟尿嘧啶500mg/m2ivd1～5,對照組:5F+CF用法用量同治療組。
Methods Eighteen patients with advanced gastric carcinoma received chemotherapy of ELFP regimen (epirubicin 60 mg/m2 iv,cisplatin 30 mg/m2 iv dl-d5,leucovorin 150 mg/m2,dl-d5,5-FU 500 mg/m2, continuous infusion for 16 hours,dl-d5,q28d).
甲酰四氫葉酸鈣(LV)150 mg/m2,靜脈推注,第1～5日。
Observation of curative effect of OXA united with Tegafur and Calcium Leucovorin for curing gastric and intestinal cancer
草酸鉑聯(lián)合替加氟及甲酰四氫葉酸鈣治療胃腸腫瘤的療效觀(guān)察
The Effect of 5-Fu with CF on Apoptosis of the Mammary Cancer Cells
5-氟尿嘧啶與甲酰四氫葉酸鈣聯(lián)合用藥對乳腺癌細胞凋亡的影響
Clinical Observation on Domestic Oxaliplatin Combined with Fluorouracil-MTX-CF in Treating Advanced Earcinoma of Large Intestine
國產(chǎn)奧沙利鉑聯(lián)合氟尿嘧啶-甲酰四氫葉酸鈣治療晚期大腸癌的療效觀(guān)察
A clinical study of CF,5-Fu and L-OHP on the patients with on advanced colorectal cancer
甲酰四氫葉酸鈣、5-氟脲嘧啶、奧沙利鉑聯(lián)合治療晚期大腸癌療效觀(guān)察
Capecitabine in combination with leucovorin and oxaliplatin as adjuvant chemotherapy in the treatment of advanced colorectal cancer
卡培他濱聯(lián)合甲酰四氫葉酸鈣和奧沙利鉑治療晚期結直腸癌的臨床觀(guān)察
Observation of Calium Folinate Treating Toxicity with Methotrextte
四氫葉酸鈣解救甲氨蝶呤不良反應觀(guān)察
N 5-methyl-tetrahydrofolic acid N 5-
甲基四氫葉酸N 5,N
Antioxidant Effect of 5-Methyltetrahydrofolate Stronger Than Ascorbic Acid
5-甲基四氫葉酸抗氧化效應強于維生素C(英文)
Study on the Synthesis of Calcium Formate by Calcium Hydroxide Carbonylation;
氫氧化鈣羰基化合成甲酸鈣工藝研究
Cyclization of β-Aroylpropionic Acid and Its Reaction with Thiazolidine-2-Thione
β-芳甲酰丙酸的環(huán)合及同四氫噻唑-2-硫酮的反應
Association between Methylene Tetrahydrofolate Reductase (MTHFR) Gene C677T Polymorphism and Hyperuricemia;
亞甲基四氫葉酸還原酶基因C677T多態(tài)性與高尿酸血癥的相關(guān)性研究
Study on the Correlation between Hypertensive Disorder Complicating Pregnancy and the MTHFR Gene Polymorphism;
亞甲基四氫葉酸還原酶基因多態(tài)性與妊娠期高血壓疾病的關(guān)系
A Rapid Detection System for C677T Polymorphism of MTHFR Gene;
亞甲基四氫葉酸還原酶基因C677T多肽性快速檢測系統的建立
Gastric Cancer Risk and Methylenetetrahydrofolate Reductase Polymorphisms;
亞甲基四氫葉酸還原酶基因多態(tài)性與胃癌關(guān)系的研究
Methylenetetrahydrofolate reductase gene polymorphism and congenital heart disease
亞甲基四氫葉酸還原酶基因多態(tài)性與先天性心臟病
Study on the polymorphysm of MTHFR gene in Hui patient with coronary heart disease in Ningxia
寧夏回族冠心病患者亞甲基四氫葉酸還原酶基因多態(tài)性的研究
Association between Polymorphism of Methylenetetrahydrofolate Reductase C677T and Coronary Heart Disease
亞甲基四氫葉酸還原酶基因C677T多態(tài)性與冠心病的關(guān)聯(lián)性研究
Polymorphisms of MTHFR among Han population in Henan area
河南漢族人群亞甲基四氫葉酸還原酶基因多態(tài)性檢測